Tessera Grants CEO 1 Million Stock Options Tied to 2027 EBITDA Targets
Tessera incentivizes leadership with a 1,000,000 share option grant at $1.15, linking long-term executive compensation to specific 2027 EBITDA performance benchmarks.
Tessera incentivizes leadership with a 1,000,000 share option grant at $1.15, linking long-term executive compensation to specific 2027 EBITDA performance benchmarks.
Elauwit Connection faces a formal investigation by Rosen Law Firm over potential securities claims, raising concerns regarding the accuracy of the company's…
Driven by a 21.29% annual growth rate in Kubernetes-native virtualization, the global data center market is set for sustained expansion through 2035,…
Hyliion Holdings Corp. faces a new class action lawsuit as legal counsel seeks lead plaintiffs for investors who suffered significant losses in…
The metamaterials sector anticipates a robust CAGR as industries integrate advanced electromagnetic and acoustic properties into next-generation hardware and communication systems.
DEWALT and August Robotics gain industry recognition for the DALE robot, a specialized construction tool designed to accelerate data center infrastructure development…
Land O'Lakes taps Clear Channel Outdoor and Getty Images for a national campaign focused on rural representation, utilizing out-of-home media and custom…
DXC Technology enhances its Assure platform with AI-driven features to streamline insurance operations for its base of more than 275 global clients.
Vidu debuts its Q4 Preview model, introducing enhanced visual effects and camera work to its AI video suite as the firm pushes…
SuperTurbo Technologies appoints automotive industry veteran Sandy Stojkovski as CEO to spearhead global powertrain operations and strategic expansion.
Southern Linc, a subsidiary of Southern Company, bolsters its board with the appointment of wireless industry veteran Benton to oversee strategic emergency…
While GLP-1 users report high levels of health optimism, nearly 50% express concern over the long-term financial trade-offs between funding their prescriptions…